Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07810829) titled 'Prognostic Value of CAR, AFR and Ferritin in Non-M3 AML' on Sept. 1.
Study Type: Observational [Patient Registry]
Primary Sponsor: Assiut University
Condition:
Acute Myeloid Leukemia
Non-M3 Acute Myeloid Leukemia
De Novo Acute Myeloid Leukemia With Multilineage Dysplasia
Recruitment Status: Not recruiting
Date of First Enrollment: September 1, 2026
Target Sample Size: 208
To know more, visit https://clinicaltrials.gov/study/NCT07810829
Disclaimer: Curated by HT Syndication....